Highlights

07-30 AptarGroup Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook MT
07-30 Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on February 5, 2026. CI
07-30 (ATR) AptarGroup, Inc. Expects Q3 Adjusted EPS Range $1.45 - $1.53 MT
07-30 Earnings Flash (ATR) AptarGroup, Inc. Reports Q2 Revenue $1.03B, vs. FactSet Est of $1.01B MT
07-30 Earnings Flash (ATR) AptarGroup, Inc. Posts Q2 Adjusted EPS $1.42 per Share, vs. FactSet Est of $1.35 MT
07-30 AptarGroup, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
07-16 AptarGroup Keeps Quarterly Dividend at $0.48 a Share, Payable Aug. 20 to Shareholders of Record July 30 MT
07-16 Aptargroup, Inc Declares Quarterly Cash Dividend, Payable on August 20, 2026 CI
05-06 AptarGroup, Inc. Introduces Patented Reloadable Airless Packaging Solution for Clarins Total Eye Lift Eye Cream CI
04-30 Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on October 10, 2024. CI
04-30 Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on February 5, 2026. CI
04-30 AptarGroup Q1 Adjusted Earnings Fall, Revenue Rises MT
04-30 (ATR) AptarGroup, Inc. Expects Q2 Adjusted EPS Range $1.32 - $1.40 MT
04-30 Earnings Flash (ATR) AptarGroup, Inc. Reports Q1 Revenue $982.9M, vs. FactSet Est of $956.0M MT
04-30 Earnings Flash (ATR) AptarGroup, Inc. Posts Q1 Adjusted EPS $1.19 per Share, vs. FactSet Est of $1.15 MT
04-30 AptarGroup, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-27 AptarGroup, Inc. Launches Inverted Lidless Dispensing Closures For Beauty And Personal Care Markets CI
04-23 AptarGroup Keeps Quarterly Dividend at $0.48 a Share, Payable May 27 to Shareholders of Record May 6 MT
04-23 AptarGroup, Inc. Declares Quarterly Cash Dividend, Payable on May 27, 2026 CI
04-08 Aptar Partners With Enable Injections for enFuse Digital Service MT
03-19 AptarGroup, Inc.?s Unidose Powder Nasal Delivery System Utilizes in ENA Respiratory Phase II Clinical Study of INNA-051 CI
03-16 AptarGroup, Inc. Utilizes Proprietary Nasal Delivery System In LTR Pharma Limited?s Phase II Clinical Study For Spontan Nasal Spray CI
02-05 AptarGroup Q4 Non-GAAP Earnings Fall, Revenue Rises; Shares Advance After Hours MT
02-05 (ATR) AptarGroup, Inc. Expects Q1 Adjusted EPS Range $1.13 - $1.21 MT
02-05 Earnings Flash (ATR) AptarGroup, Inc. Reports Q4 Revenue $962.7M, vs. FactSet Est of $878.6M MT
No results match your criteria